"Propranolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
| Descriptor ID |
D011433
|
| MeSH Number(s) |
D02.033.100.624.698.711 D02.033.755.624.698.711 D02.092.063.624.698.711 D02.455.426.559.847.638.945 D04.615.638.945
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propranolol".
Below are MeSH descriptors whose meaning is more specific than "Propranolol".
This graph shows the total number of publications written about "Propranolol" by people in this website by year, and whether "Propranolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 2000 | 0 | 2 | 2 |
| 2002 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propranolol" by people in Profiles.
-
Snyder AE, Salimando GJ, Winder DG, Silberman Y. Chronic Intermittent Ethanol and Acute Stress Similarly Modulate BNST CRF Neuron Activity via Noradrenergic Signaling. Alcohol Clin Exp Res. 2019 08; 43(8):1695-1701.
-
Moraco AH, Banauch G, Kopec S. A 46-Year-Old Woman With Dyspnea From an Inhalational Exposure, Triggering Thyroid Storm and Subsequent Multi-Organ System Failure. J Intensive Care Med. 2015 Dec; 30(8):518-20.
-
Baek K, Hwang HR, Park HJ, Kwon A, Qadir AS, Baek JH. Propranolol, a ?-adrenergic antagonist, attenuates the decrease in trabecular bone mass in high calorie diet fed growing mice. BMB Rep. 2014 Sep; 47(9):506-11.
-
Hoffmann TJ, Simon BJ, Zhang Y, Emala CW. Low voltage vagal nerve stimulation reduces bronchoconstriction in guinea pigs through catecholamine release. Neuromodulation. 2012 Nov-Dec; 15(6):527-36.
-
Goodman IS, Lu CJ. Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia. Pediatr Emerg Care. 2012 Jan; 28(1):47-8.
-
Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, Robertson D. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009 Sep 01; 120(9):725-34.
-
Schepke M, Wiest R, Flacke S, Heller J, Stoffel-Wagner B, Herold T, Ghauri M, Sauerbruch T. Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study. Am J Gastroenterol. 2008 May; 103(5):1152-8.
-
Maykel JA, Pazirandeh S, Bistrian BR. Beta-blockade and severe burns. N Engl J Med. 2002 Feb 28; 346(9):707-8.
-
Ethier MF, Dextradeur T, Schaefer OP, Madison JM. Effects of salmeterol on muscarinic inhibition of adenylyl cyclase in bovine trachealis cells. Life Sci. 2000 Oct 20; 67(22):2753-8.
-
Mattocks KM, Horwitz RI. Placebos, active control groups, and the unpredictability paradox. Biol Psychiatry. 2000 Apr 15; 47(8):693-8.